+86-2988253271

Cov txiaj ntsig ntawm Hydroxytyrosol yog dab tsi?

Mar 13, 2024

Nrog rau qhov tob ntawm kev tshawb fawb, hydroxytyrosol txiv ntseej nploojrho tawmNws muaj zog ntau dua li txiv ntseej bittersweet hauv kev ua haujlwm tua kab mob thiab tshuaj tua kab mob. Hydroxytyrosol (hydroxytyrosol, HT) tshuaj npe 3, 4 a dihydroxyphenylethanol. Nws muaj zog antioxidant kev ua haujlwm. Feem ntau nyob rau hauv daim ntawv ntawm esters nyob rau hauv cov txiv ntseej txiv ntoo thiab ceg thiab nplooj. HT monomer yog tau tom qab hydrolysis ntawm txiv ntseej bittersweet, uas muaj ib tug yooj yim qauv thiab me me molecular hnyav. Nws muaj cov tshuaj zoo thiab kev saib xyuas kev noj qab haus huv. Nws tau muaj kev txhawj xeeb los ntawm cov kws tshawb fawb hauv tsev thiab txawv teb chaws.

news-458-321

• Kev tshawb fawb txog kev tiv thaiv thrombosis, ntshav lipid kev tswj thiab kev tiv thaiv atherosclerosis

Nws tau pom tias kev noj cov roj txiv roj tuaj yeem txo qhov tshwm sim ntawm cov kab mob plawv. Ntawm lawv, HT ua lub luag haujlwm tseem ceeb. Nws tau raug taw qhia tias cov txiaj ntsig ntawm HT ntawm cov kab mob plawv muaj feem cuam tshuam nrog inhibition ntawm platelet aggregation, thiab GonzIlez-Correa et al. tshuaj xyuas cov nyhuv anti-agglutination ntawm HT ntawm cov ntshav nas hauv vitro nrog salicylic acid raws li kev siv. Cov txiaj ntsig tau pom tias nws inhibits thromboxane B synthesis. Qhov no ua rau kev tsim cov nitrous oxide, uas ua rau cov nyhuv anticoagulant. deRoos et al. tshuaj xyuas cov nyhuv anticoagulant ntawm HT siv tib neeg cov ntshav raws li kev kawm. Ntawm qhov concentration ntawm 100 mg / L, cov kev tshawb fawb proteomic qhia tau hais tias nws tau koom nrog hauv kev tswj hwm ntawm cuaj cov proteins uas ua rau muaj kev cuam tshuam rau cov coagulant. Xws li cov qauv platelet, kev ua haujlwm thiab integrin aIIb / b3 hloov pauv. Los ntawm cov txiaj ntsig, nws pom tseeb tias HT inhibits platelet kev ua haujlwm thiab adhesion thiab tuaj yeem siv los tiv thaiv thrombosis.

Cov nyhuv anticardiovascular ntawm HT tuaj yeem cuam tshuam nrog txo cov ntshav qabzib thiab lipid oxides concentration. Nws tau raug pov thawj tias HT tuaj yeem txo qhov concentration ntawm cov ntshav qabzib hauv plasma thiab tus nqi ntawm triacylglycerol thiab tag nrho cov roj (cholesterol) hauv cov ntshav qab zib nas. Nws kuj tseem txhim kho SOD, catalase (CAT) thiab glutathione (GSH) peroxidase cov haujlwm hauv daim siab thiab lub raum. Nws txo cov qib ntawm alkaline phosphatase thiab thiobarbituric acid reactants, ntawm lwm tus, yog li nthuav tawm qhov txo qis hauv daim siab thiab lub raum toxicity. Cov txheej txheem yuav cuam tshuam nrog HT thiab LDL khi. Nws kuj tau qhia tiashydroxytyrosol txiv ntseej nploojrho tawmtuaj yeem kho hyperglycemia thiab oxidative kev nyuaj siab los ntawm ntshav qab zib.

news-405-266

HT tuaj yeem tiv thaiv kev txhim kho ntawm atherosclerosis.Zrelli li al. pom tau hais tias txiv ntseej nplooj hydroxytyrosol tuaj yeem txo cov qib ntawm hydrogen peroxide-induced ROS hauv porcine pulmonary artery epithelial hlwb. Nws kuj tau txhim kho cov qib ntawm mRNA enzymes, kev ua haujlwm ntawm cov protein thiab intracellular transcriptional regulator 3a (FOXO3a), thiab induced adenosine monophosphate-activated protein kinase los hloov FOXO3a rau lub nucleus. Ntawm lwm yam FOXO3a yog tus tswj hwm kev hloov pauv. Nws yog feem ntau pom nyob rau hauv cov ntaub so ntswg plawv, thiab nws lub xeev activated muaj qhov cuam tshuam loj rau inhibiting vascular du nqaij proliferation, cardiomyocyte hyperplasia thiab hypertrophy, thiab anti-oxidative kev nyuaj siab. Txawm li cas los xij, nws yog inactivated thaum nws thauj los ntawm lub nucleus mus rau cytoplasm. HT tiv thaiv lub cev epithelial hlwb los ntawm oxidative kev puas tsuaj los ntawm inducing qhia ntawm adenylate-activated protein kinase thiab activating cov kev ua ntawm FOXO3a enzyme thiab tiv thaiv kev loj hlob ntawm atherosclerosis. Tsis tas li ntawd, HT yog ib qho muaj zog intracerebral antioxidant. Nws tau pom tias yuav txo qis cov lipid peroxidation cov khoom nyob rau hauv lub striatum thiab cov so ntawm lub hlwb, thiab mus impede lub depletion ntawm GSH. Kev noj cov zaub mov uas muaj HT txo qis kev pheej hmoo ntawm lub hlwb neuropathy. Tag nrho cov kev tshawb fawb saum toj no qhia tau hais tias HT txo cov nqi ntawm cov pa oxygen reactive nyob rau hauv lub hlwb thiab vascular endothelium, muab lub hauv paus molecular rau kev kho mob plawv thiab cerebrovascular kab mob.

• Kawm txog cov teebmeem antipathogenic microbial

HT tej zaum yuav raug tsim los ua tshuaj rau kev kho mob plab hnyuv thiab ua pa. Nws muaj txiaj ntsig zoo thiab dav-spectrum. Noj Helicobacter pylori ua piv txwv, nws muaj ntau hom tshuaj tiv thaiv kab mob thoob ntiaj teb. Txawm li cas los xij, HT muaj peev xwm tua cov nyhuv ntawm ob qho tib si resistant thiab non-resistant hom. Hauv lwm txoj kev tshawb fawb, qhov qis tshaj inhibitory concentration ntawm HT ntawm 5 tus qauv hom (ATCC9{{10}}06, ATCC8176, ATCC6539, ATCC17802, ATCC25923) thiab 44 hom tau txais kev kho mob yog 0.{11}}. 85 g/mL, 0.97-31.25 g/mL, feem. qhov inhibitory concentration tau qis dua li ntawm lwm cov nroj tsuag rho tawm. Thiab cov kev ua ntawm inhibiting Gram-zoo kab mob yog siab dua li ntawm cov kab mob Gram-tsis zoo. Nws yog noteworthy tias nws cov tshuaj tua kab mob tsis tau tsuas yog tshwm sim tawm tsam cov kab mob phem nyob rau hauv txoj hnyuv. Nws kuj tseem inhibit cov kab mob lactophilic thiab bifidobacteria.

Txiv ntseej nplooj extract hydroxytyrosol tseem tuaj yeem cuam tshuam cov haujlwm ntawm ntau tus kab mob. Cov no suav nrog HIV-1, H1N1, H3N2, H5N1 thiab H9N2 subtypes thiab Newcastle fowl plague virus. Txawm li cas los xij, nws tsis zoo rau bovine rotavirus thiab adenovirus.Lee.Huang li al. "pom tias HT tuaj yeem txo qhov kev ua haujlwm ntawm HIV-1 fusion enzyme. Thiab tuaj yeem cuam tshuam fusion ntawm cov active core ntawm gp los ntawm kev tsim hydrogen bonds nrog cov hydrophobic pawg nyob rau hauv txheej txheej ntawm lub hnab ntawv viral . Tom qab Yamada li al Cov. Tas tau pom tias kev ua tiav ntawm tus dev raum (MDCK) nrog HT tsis muaj kev cuam tshuam uas tsis muaj protein tsis tuaj yeem kuaj pom. Ntxiv mus , morphology ntawm H9N2 tus kab mob hloov tom qab HT kev kho mob tau soj ntsuam los ntawm electron microscopy Qhov no qhia tau hais tias lub hom phiaj yog lub hnab ntawv los yog lwm qhov chaw ntawm tus kab mob nws tus kheej, tsis yog lub host cell.hydroxytyrosol txiv ntseej nploojrho tawmtsis tuaj yeem tsuas yog siv los ua tshuaj tua kab mob thiab tshuaj tua kab mob. Thiab nws tseem tuaj yeem txhim kho lub cev tiv thaiv kev ua haujlwm. Highlighting nws lub peev xwm rau txoj kev loj hlob raws li ib tug antipathogenic microbial tshuaj.

• Kev tshawb fawb txog kev tiv thaiv pob txha mos thiab tiv thaiv kab mob osteoporosis

Pob txha mos yog cov ntaub so ntswg ntom ntom uas tsim los ntawm osteoblastic mos hlwb lossis chondrocytes thiab lwm yam khoom. Embedded hauv extracellular matrix, nws yog ib qho tseem ceeb ntawm cov pob txha. Vim nws cov metabolism hauv qis, pob txha mos rov qab tom qab raug mob los yog tawg yog qeeb.HT induces thiab txhim khu chondrocyte proliferation thiab tsub kom nws muaj peev xwm los tsim extracellular matrix Cheebtsam, li no txhawb pob txha mos kho thiab regeneration.Hagiwara li al. tshuaj xyuas cov teebmeem ntawm HT ntawm cov pob txha tsim thiab cov pob txha poob tom qab tshem tawm ntawm zes qe menyuam, siv osteoblasts thiab osteoclasts raws li lub hom phiaj. Ntawm qhov siab ntawm 10-100 mol / L, hydroxytyrosol hauv cov khoom noj tau txhawb nqa calcium deposition raws li koob tshuaj. Txawm li cas los xij, nws tsis muaj qhov cuam tshuam rau collagen thiab alkaline phosphatase hauv thawj osteoblasts. Ntawm qhov siab ntawm 50-100 mol / L, HT tiv thaiv kev tsim ntawm multinucleated osteoclasts nyob rau hauv koob tshuaj, thiab HT inhibited pob txha poob hauv de-ovulated femoral trabecular osteoblasts. Nws kuj txo H₂O₂ qib hauv pro-osteoblasts, uas tiv thaiv pob txha los ntawm oxidative stress.HT plays lub luag haujlwm tseem ceeb hauv kev tsim cov pob txha thiab kev saib xyuas cov pob txha noj qab haus huv, thiab tuaj yeem siv los ua cov tshuaj zoo hauv kev kho pob txha. Nws yog tsim rau inducing los yog txhim kho pob txha mos los yog pob txha mos regeneration, tshwj xeeb tshaj yog rau cov neeg ncaws pob thiab cov neeg uas muaj active lub neej.

news-444-284

 

• Kawm txog cov nyhuv ntawm retinal macular degeneration tiv thaiv thiab kho

HT tiv thaiv oxidative kev puas tsuaj rau lub retinal epithelium tshwm sim los ntawm acrolein, ib puag ncig toxicity, oxidized fatty hais thiab laus. Nws yog qhov tshwj xeeb tshaj yog tsim rau cov neeg laus kom muaj kev noj qab haus huv ntawm qhov muag thiab kev daws teeb meem siab thiab txhim kho kev pom. Nyob rau hauv tib neeg retinal epithelial hlwb APRE I 19, HT tiv thaiv ob qho tib si Nrf2 cellular txoj kev thiab activates lub coenzyme PPARGC1 receptor.Nrf2 activates theem II purifying enzymes. Nrf2 activates theem II purifying enzymes, xws li monoglutamyl thiab cysteyl ligases, NADPH quinone oxidoreductase 1, erythrocyte synthase 1, thiab lwm yam antioxidant enzymes, uas "khi" rau cov dawb radicals thiab hloov lwm yam tshuaj lom mus rau hauv tsawg reactive molecules. PPARGC1, ntawm qhov tod tes, uncoils protein 2 thiab mitochondrial complex los txhim kho kev qhia ntawm mitochondrial transporter A los tiv thaiv mitochondrial tsis ua haujlwm. Qhov no txhim kho cell ciaj sia. Yog li hydroxytyrosol hmoov txiv ntseej nplooj extract induces theem II purifying enzyme kev ua si thiab txhim kho mitochondrial ntau lawm, yog li tiv thaiv los yog kho macular degeneration.

• Lwm yam kev tshawb fawb txog kev noj qab haus huv

HT txo qis kev tsim ntawm intracellular COX I-2 thiab kev qhia ntawm 5-monooxygenase, thiab txo cov synthesis ntawm prostaglandin E-2. Nws tuaj yeem siv los ua cov tshuaj tua kab mob thiab tshuaj tua kab mob.HT pab kho mitochondria puas los ntawm kev tawm dag zog ntau dhau los yog kev tawm dag zog, uas tuaj yeem ua rau rov qab sai ntawm lub cev muaj zog thiab txhim kho kev tiv thaiv thiab kev muaj peev xwm kis las. Nws tseem tuaj yeem txo qhov tsim cov roj ntsha hauv C3H10T1 / 2 hlwb ntawm nas, thiaj li ua tiav lub hom phiaj ntawm kev poob phaus.

 

Cov kws tshawb fawb txawv teb chaws tau tshawb fawb zoo ntawm cov tshuaj pharmacological ntawm HT hauv kev tswj cov ntshav lipids thiab tiv thaiv atherosclerosis, tiv thaiv kab mob kab mob, tiv thaiv thiab tswj cov retinal macular degeneration, tiv thaiv pob txha mos thiab tiv thaiv osteoporosis thiab lwm yam. Qee qhov kev tshawb fawb kuj tau tshawb nrhiav cov tshuaj pharmacological ntawm HT ntawm qib molecular. Kev tshawb fawb hauv tsev ntawm HT feem ntau yog hauv cov khoom noj qab haus huv thiab cov khoom noj ntxiv. Nws muaj tsawg dua kev tshawb fawb ntawm nws cov tshuaj siv. Tsis ntev los no, Liu Health et al. thov rau patent rauhydroxytyrosol txiv ntseej nploojrho tawmrau kev kho mob qog noj ntshav prostate.

Yog tias muaj lus nug, thov hu rau peb ntawminfo@gybiotech.com.

Xa kev nug